A three-year clinical trial led by Dr. Edwin Kim at the UNC School of Medicine has demonstrated that sublingual immunotherapy (SLIT) is a safe and effective treatment for peanut-allergic children aged 1 to 4. The trial found that SLIT, which involves a small amount of peanut protein absorbed under the tongue, was highly effective in treating peanut-allergic toddlers. After completing the treatment, almost 80% of participants could tolerate 15 peanuts without allergic symptoms. Moreover, 63% of toddlers maintained their protection against peanut allergy three months after stopping the treatment. Peanut SLIT offers a promising approach for early intervention in peanut allergies, with a focus on safety and efficacy.
New Peanut Allergy Treatment for Toddlers Shows Promise
Теги
Toddlers Allergic to PeanutsTiny Bit of Protein Therapy Under the Tongue Could Be The Best Approachsublingual immunotherapy4 mg peanut SLIT versus placebohighly effective in treating peanut-allergic toddlerstypical peanut-allergic reactionspeanut allergypeanut allergy symptomsnut allergyallergiesfood allergyallergy seasonskin allergypeanut allergy treatment for toddlersallergic reactiondesensitizing toddlers to peanutsViaskin Peanutside effect
